L534
Pill imprint L534 has been identified as Naproxen 375 mg.
Naproxen is used in the treatment of pain; back pain; headache; osteoarthritis; sciatica (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Naproxen 375 mg is not subject to the Controlled Substances Act.
See also related documents.
Naproxen Images
- Imprint:
-
L534
- Strength:
- 375 mg
- Color:
- White
- Size:
- 14.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- croscarmellose sodium
magnesium stearate
povidone
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Perrigo Company
- National Drug Code (NDC):
- 45802-0534
| NDC Code | Manufacturer / Repackager |
|---|---|
| 49999-0049 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Naproxen resources
- Naproxen
- Naproxen (Wolters Kluwer)
- Naproxen Enteric-Coated Tablets (Wolters Kluwer)
- Naproxen Suspension (Wolters Kluwer)
- Naproxen Sustained-Release Tablets (Wolters Kluwer)
- naproxen (Cerner Multum)
- Naprelan 500 (Micromedex) - Includes Dosage Information
- Naprelan Dose Card (Micromedex) - Includes Dosage Information
- Naxen (Micromedex) - Includes Dosage Information
- naproxen (Micromedex) - Includes Dosage Information
- Naproxen (AHFS DI)
- Naproxen Sodium (AHFS DI)
- Good Neighbor All Day Pain Relief (FDA)
- Naprosyn Tablets (FDA)
- Naproxen (FDA)
- Naproxen Capsules (FDA)
- Naproxen Delayed Release (FDA)
- Naproxen Tablets (FDA)
- Topcare All Day Pain Relief (FDA)
- Up and Up Naproxen Sodium (FDA)
- Naproxen (Wolters Kluwer)
Search Again
